Protozoan parasites of Leishmania genus are able to successfully infect their host macrophage due to multiple virulence strategies that result in its deactivation. Recent studies suggest Leishmania GP63 to be a critical virulence factor in modulation of many macrophage molecules, including protein tyrosine phosphatases (PTPs) and transcription factors (TFs). Additionally, we and others recently...

The protozoan Trypanosoma cruzi expresses multiple isoforms of the GP63 family of metalloproteases. Polyclonal antiserum against recombinant GP63 of T. cruzi (TcGP63) was used to study TcGP63 expression and localization in this organism. Western blot analysis revealed that TcGP63 is 61 kDa in epimastigotes, amastigotes, and tissue culture-derived trypomastigotes but 55 kDa in metacyclic trypoma...

The zinc protease (gp63) of promastigotes was found to play a role in the sand fly part of the Leishmania life cycle. Lutzomyia longipalpis females were fed with promastigotes (10(6) per ml) of a Leishmania amazonensis clone whose gp63 was up- and down-regulated by directional cloning into P6.5 for sense- and anti-sense transcription. Early development was found to differ significantly between ...

Leishmania parasites have evolved sophisticated mechanisms to subvert macrophage immune responses by altering the host cell signal transduction machinery, including inhibition of JAK/STAT signalling and other transcription factors such as AP-1, CREB and NF-κB. AP-1 regulates pro-inflammatory cytokines, chemokines and nitric oxide production. Herein we show that upon Leishmania infection, AP-1 a...

A virus-specific glycoprotein (gp) from human herpes-virus 6 (HHV-6) was studied using the anti-HHV-6 monoclonal antibody OHV1. Immunoprecipitation with extracts from infected cells revealed that the antibody recognized four glycosylated proteins (gps) with Mrs of 106K, 102K, 65K and 63K under reducing conditions. However, only two gps, of 106K (gp106) and 102K, were detected under non-reducing...

The intramacrophage protozoan parasites of Leishmania genus have developed sophisticated ways to subvert the innate immune response permitting their infection and propagation within the macrophages of the mammalian host. Several Leishmania virulence factors have been identified and found to be of importance for the development of leishmaniasis. However, recent findings are now further reinforci...

Visceral leishmaniasis is a macrophage associated disorder which leads to a profound decrease in the natural immunotherapeutic potential of the infected subjects to combat the disease. The major surface glycoprotein gp63 has been found to be a significant vaccine candidate against visceral leishmaniasis. The current study addresses the levels of similarity and identity in the gp63 obtained from...

Leishmaniasis, caused by protozoa of the genus Leishmania, encompasses a group neglected diseases with diverse clinical and epidemiological manifestations that can be fatal if not adequately promptly managed/treated. The current chemotherapy options for this disease are expensive, require invasive administration often lead to severe side effects. In regard, our research has previously reported ...

The attachment of tail fibers to tail-fiberless T4 particles in extracts of mutant-infected cells proceeds slowly in the absence of gene product Cgp) 63, but can be stimulated up to 50-fold by its presence, supporting the view that gp63 acts catalytically to increase the rate of tail fiber attachment. The active protein has been purified about loo-fold to yield a nearly homogeneous preparation....

BACKGROUND Leishmaniasis is a worldwide disease prevalent in tropical and sub tropical countries. Many attempts have been made and different strategies have been approached to develop a potent vaccine against Leishmania. DNA immunisation is a method, which is shown to be effective in Leishmania vaccination. Leishmania Soluble Antigen (SLA) has also recently been used Leishmania vaccination. M...